Detroit’s Barbara Ann Karmanos Cancer Institute and Crittenton Hospital Medical Center in Rochester Hills, Mich., have agreed to dissolve their joint venture agreement over a new cancer facility, according to a Detroit Free Press report.
Effective July 1, Crittenton will assume sole management and ownership of the $16 million cancer facility. The two providers had operated the center as a joint venture since Feb. 2010.
A Crittenton spokesperson declined to say why the joint venture was ending, according to the report. The hospital will continue its affiliation agreement with Karmanos, with Karmanos providing additional cancer care to Crittenton patients.
Read the Detroit Free Press report on Karmanos Cancer Institute and Crittenton Hospital Medical Center.
Related Articles on Joint Ventures:
Optimizing a Hospital-Physician Joint Venture: 4 Tips for a Culture of Partnership
North Carolina’s Pardee Hospital, Mission Health to Form Joint Venture Outpatient Facility
5 Problems That Hurt a Hospital-Physician ASC Joint Venture — and How to Avoid Them
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
